Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
End Game depicts visionary medical providers who practice on the cutting edge of life and death, changing the way we think about both.
Scientists emphasize using data and analyses from completed and ongoing trials to gain a better understanding of patient outcomes.
Trust, family, community, cooperation, resiliency, embracing absurdity, and pursuing goals are touchstones of a meaningful life.
When I manage to capture the experience shared by so many others, I am reminded of my strengths and the privilege I have to raise my voice.
If you are facing your own experience of illness or are affected by those who are, this post may shine a light on these challenges.
Some of the most common and deadly cancers receive little attention and resources.
The problem with this attitude is that if anything goes—if everything is permissible—then nothing matters.
The National Brain Tumor Society on research, progress and the eighth annual Head to the Hill
All 12 treated children with NTKR, ROS1 or ALK gene abnormalities showed partial or compete tumor shrinkage.
“It is unthinkable that a doctor could tell you that there is nothing that can be done for your child,” says Kathryn R. Taylor, PhD.
An ongoing study is assessing pediatric and young adult cancers that did not respond to initial treatments.
The vaccine, based on an individual’s own tumor cells, improved survival time and proved safe in an early-stage trial.
Join us Sunday, April 28, 2019, to raise money, awareness, and connectedness with and for the National Brain Tumor Society!
While her response is not average, doctors say it represents a step forward for people with diffuse midline gliomas, a rare cancer.
Angela J. Waanders, MD, MPH, is tackling pediatric brain cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.